Behind the Money cover image

Best Of: Why companies don't want to list in the UK anymore

Behind the Money

00:00

Introduction

This chapter explores the fundraising challenges faced by Amunocor, a British biotech firm, as they turned to US investors for additional funding. It also highlights the positive results from their clinical trial in 2020.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app